go-v.orgdoi

Reduced survival of young patients under 55 years with metastatic prostate cancer: a population-based study

Pan Song, Zhufeng Peng, Mengxuan Shu, Jiaxiang Wang, Peiwen Liu, Xiaoyu Di, Luchen Yang, Zhenghuan Liu, Jing Zhou, Qiang G Dong · Journal of Cancer · 2021

  • DOI 10.7150/jca.58144
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2021

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2021

Abstract

Objective: The aim of this study was to evaluate the prognosis of patients with metastatic prostate cancer (mPCa) in different age groups.Methods: Patients with mPCa from 2004 to 2016 in the Surveillance, Epidemiology and End Results (SEER) database were identified.Seven groups were divided according to the age at diagnosis, including ≤55 years, 56-60 years, 61-65 years, 66-70 years, 71-75 years, 76-80 years and >80 years.Fine and Gray's competing risks model and Kaplan-Meier analysis were conducted to evaluate the cancer-specific survival (CSS).Results: A total of 36231 patients with mPCa were included.The CSS curves of the overall cohort showed that patients aged ≤55 years had significantly worse CSS than patients in age groups of 56-60 [HR:0.93(0.87~1.00), p=0.039], 61-65 [HR:0.91 (0.85~0.97), p=0.003] and 66-70 [HR:0.90(0.84~0.96), p=0.001].After removing patients dead for other reasons, the differences of CSS curves between ≤55 years group and 56-70 years groups were not significant.However, the mean survival time of ≤55 years group (55.78±2.48months) was still shorter than 56-60 years (57.28±2.35months), 61-65 years (57.64±2.07months), and 66-70 years (57.11±2.11months).When stratified by M stages, similar results were found in M1a, M1b and M1c stage groups.According to Fine-Gray competing risks models, patient ≤55 years featured significantly higher sub-distribution hazard ratio (sdHR) than 61-65 years group [sdHR: 0.94(0.88~1.00);p=0.046].

Conclusions:The mPCa patients ≤55 years seemed to be associated with worse prognosis in comparison with patients aging 56-70 years.

Open the resolved locator · 10.7150/jca.58144

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:36 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v12p4985.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.